NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

ASTEC LIFESCIENCES LIMITED’s Quarterly Result and Earnings Report for Q4(Mar 2024) : Sales increased by 21.09 % in YoY and increased by 202.68 % in QoQ

May 8, 2024May 8, 2024| adminadmin| 0 Comments| 5:45 pm
Image is loading
Categories:

Share the post "ASTEC LIFESCIENCES LIMITED’s Quarterly Result and Earnings Report for Q4(Mar 2024) : Sales increased by 21.09 % in YoY and increased by 202.68 % in QoQ"

  • Facebook
  • LinkedIn
  • X
  • Tumblr
  • WhatsApp
  • TelegramTelegram
  • Email

Highlights

  • Sales over the Year and quarter: The company experienced a substantial growth of 21.09 % in the past year, substantial increase in net sales/revenue by 202.68 %.
  • Income over the Year and quarter: There has been decline in other income over the past year which is -20.23 %, Marginal increase in other income during this quarter, up by 125.27%.
  • Profit over the Year and quarter: Challenges in sustaining profitability for ASTEC LIFESCIENCES LIMITED. Profit dropped by -80.62 % Year to Year, ASTEC LIFESCIENCES LIMITED’s profitability dropped by -96.04 % Quarter to Quarter.
  • EPS over the Year and quarter: EPS declined by -119.69 % Year to Year. EPS decreased by -104.03 % in previous quarter. Analysis needed for shareholder value.

The comprehensive analytics outlining the performance and outlook of ASTEC LIFESCIENCES LIMITED”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 126.972 Cr Rs. 50.795 Cr Rs. 153.748 Cr + 202.68 % + 21.09 %
Expenses Rs. 121.57 Cr Rs. 69.12 Cr Rs. 141.04 Cr + 104.05 % + 16.02 %
Operating Profit Rs. 5.4 Cr Rs. -18.33 Cr Rs. 12.71 Cr + 169.34 % + 135.37 %
OPM % 4.25 % -36.09 % 8.27 % + 44.36 % + 4.02 %
Other Income Rs. 2.57 Cr Rs. 0.91 Cr Rs. 2.05 Cr + 125.27 % -20.23 %
Interest Rs. 6.4 Cr Rs. 6.1 Cr Rs. 6.68 Cr + 9.51 % + 4.37 %
Depreciation Rs. 7.76 Cr Rs. 8.7 Cr Rs. 9.01 Cr + 3.56 % + 16.11 %
Profit before tax Rs. -6.19 Cr Rs. -32.22 Cr Rs. -0.93 Cr + 97.11 % + 84.98 %
Tax % -19.54 % -24.5 % -4.1 % + 20.4 % + 15.44 %
Net Profit Rs. -4.98 Cr Rs. -24.33 Cr Rs. -0.96 Cr + 96.05 % + 80.72 %
EPS in Rs Rs. -2.54 Rs. -12.41 Rs. 0.5 + 104.03 % + 119.69 %


Today, we’re looking at ASTEC LIFESCIENCES LIMITED’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 21.09 %. However, it did see a marginal increase of 202.68 % from the previous quarter. Expenses ticked up slightly by 104.05 % quarter-on-quarter, aligning with the annual rise of 16.02 %. Operating profit, while up 135.37 % compared to last year, faced a quarter-on-quarter increase of 169.34 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 4.02 %, but an expansion of 44.36 % sequentially. Other income rose by 125.27 % compared to the last quarter, despite an annual decline of -20.23 %. Interest expenses surged remarkably by 9.51 % from the previous quarter, yet the year-over-year increase remains at a moderate 4.37 %. Depreciation costs climbed by 3.56 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 16.11 %. Profit before tax grew annually by 84.98 % but saw an increase from the preceding quarter by 97.11 %.
Tax expenses as a percentage of profits increased slightly by 15.44 % compared to last year, with a more notable quarter-on-quarter increase of 20.4 %. Net profit rose by 80.72 % year-on-year but experienced a 96.05 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 119.69 % but a quarterly rise of 104.03 %. In summary, ASTEC LIFESCIENCES LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 126.972 Cr Rs. 50.795 Cr Rs. 153.748 Cr + 202.68 % + 21.09 %
Expenses Rs. 121.57 Cr Rs. 69.12 Cr Rs. 141.04 Cr + 104.05 % + 16.02 %
Operating Profit Rs. 5.4 Cr Rs. -18.33 Cr Rs. 12.71 Cr + 169.34 % + 135.37 %
Net Profit Rs. -4.98 Cr Rs. -24.33 Cr Rs. -0.96 Cr + 96.05 % + 80.72 %
EPS in Rs Rs. -2.54 Rs. -12.41 Rs. 0.5 + 104.03 % + 119.69 %


In reviewing ASTEC LIFESCIENCES LIMITED’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 21.09 % year-on-year growth, however, there was a minor increase of 202.68 % from the previous quarter. Expenses rose by 16.02 % compared to the previous year, with a 104.05 % increase quarter-on-quarter. Operating Profit surged by 135.37 % annually, and saw a 169.34 % increase from the last quarter.
Net Profit showed yearly increase of 80.72 %, and experienced a 96.05 % increase from the previous quarter. Earnings Per Share (EPS) rose by 119.69 % annually, however rose by 104.03 % compared to the last quarter. In essence, while ASTEC LIFESCIENCES LIMITED exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”ASTEC LIFESCIENCES LIMITED”]

Related Post